Presented by ASA’s Mental Health and Aging Network (MHAN)

ASA Members: Register now for FREE

Not a Member? Join ASA or Register for this event for $49

Includes complimentary CEUs

This web seminar is based on the 2017 Aging in America Conference (AiA) workshop, “Dementia: A Global Health Priority.”

This web seminar is a tribute to World Alzheimer”s Day, which is held annually on September 21 and marks a day on which Alzheimer’s organizations globally concentrate their efforts on raising awareness about Alzheimer’s and dementia.

Dementia impacts societies at all levels and should be addressed by all levels of government. This web seminar showcases the latest developments in global dementia policy, including the World Health Organization’s global dementia plan of action, cross-national comparisons of dementia plan activities and accomplishments, and the role of the U.S. government as a global leader in dementia care and research.

Participants in this web seminar will be able to:

• Describe four key elements of comprehensive government plans to address the needs of people with dementia;
• Describe two key activities that the World Health Organization is implementing to make an impact on health policy;
• Identify ways to engage in global action on behalf of dementia care and research; and,
• Describe the policy relevant mission and goals of the Atlantic Fellows program at the Global Brain Health Institute.

Presenters:

Dr. Brooke Hollister is an associate professor at the Institute for Health & Aging at the University of California, San Francisco, and a co-instructor (along with Kate Gordon) of the Global Brain Health Institute’s Policy course. Hollister served as a Health and Aging Policy Fellow from 2012 to 2013, working in House Minority Leader Nancy Pelosi’s office on a variety of health policy issues.

Kate Gordon is a director at Splaine Consulting in Columbia, Maryland, and a health policy analyst in the Aging, Disability, and Long-Term Care group at RTI International in Washington, D.C. She serves as a policy adviser for London, UK-based Alzheimer's Disease International, working to advance international innovation in dementia care, services, and policy.

Michael Splaine is owner and principal of Splaine Consulting in Columbia, Maryland. He previously served as director of State Government Affairs in the Public Policy Division of the U.S. Alzheimer’s Association. Splaine also serves as the public policy adviser for Alzheimer’s Disease International.